US expansion Ascentry has recently appointed a VP of Sales for the United States to lead entry into the US market, indicating a strategic push into a large, opportunity-rich healthcare IT and diagnostics ecosystem.

regulatory strengths The company maintains group-level quality and information-security frameworks with ISO 13485:2016 and ISO/IEC 27001:2022 certifications, signaling reliability for labs and IVD partners and a potential differentiator when pursuing enterprise clients with strict compliance needs.

lab-focused solutions Ascentry markets high-performance, scalable software tailored for clinical laboratories and IVD vendors, presenting opportunities to cross-sell or upsell to customers handling rising data volumes and regulatory pressures.

growth signals Mid-sized headcount (51-200 employees) and revenue in the multi-million range suggest evolving sales cycles with room for scalable deployments, partnerships, and channel strategies to accelerate adoption.

data security edge Emphasis on cybersecurity and data protection, along with ISO/IEC 27001:2022, positions Ascentry as a trusted data partner for customers prioritizing secure handling of sensitive diagnostic information.